Metoprolol Succinate 50mg Extended Release Tablet
Reviewed educational reference: what Metoprolol Succinate is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Metoprolol Succinate
- Strength
- 50mg
- Dosage form
- Extended Release Tablet
- Drug class
- Beta-blocker
Related products
No reviewed products are currently published for this generic.
Metoprolol Succinate 50mg Extended Release Tablet contains Metoprolol Succinate, a cardioselective beta-1 receptor antagonist used primarily to manage cardiovascular conditions. By blocking the effects of adrenaline on the heart, it reduces heart rate, cardiac output, and blood pressure. The extended-release formulation ensures a steady delivery of the medication throughout the day, providing consistent therapeutic control for patients with hypertension, angina pectoris, and stable heart failure.
At a glance
Metoprolol Succinate 50mg Extended Release Tablet is a cardioselective beta-1 blocker.
It reduces heart rate and blood pressure by blocking adrenaline receptors.
It is used for hypertension, angina, and heart failure.
Uses of Metoprolol Succinate
- Management of essential hypertension to lower blood pressure.
- Treatment of chronic stable angina pectoris to reduce chest pain.
- Adjunctive therapy in stable symptomatic heart failure.
- Prevention of secondary myocardial infarction.
- Management of cardiac arrhythmias, specifically supraventricular tachycardia.
- Prophylaxis of migraine headaches in susceptible individuals.
Benefits of Metoprolol Succinate
Cardiovascular Protection: Metoprolol Succinate 50mg Extended Release Tablet significantly reduces the workload on the heart by slowing the heart rate and decreasing the force of contraction. This helps in preventing long-term damage to the heart muscle and reduces the risk of future cardiac events such as heart attacks or strokes in patients with pre-existing conditions.
Consistent Symptom Control: The extended-release mechanism of Metoprolol Succinate 50mg Extended Release Tablet allows for once-daily dosing, which improves patient adherence and maintains stable plasma concentrations of the drug. This prevents the peaks and troughs associated with immediate-release formulations, leading to more reliable blood pressure regulation and fewer episodes of exercise-induced angina.
Side effects of Metoprolol Succinate
Common side effects of Metoprolol Succinate 50mg Extended Release Tablet include fatigue, dizziness, and cold extremities due to reduced peripheral blood flow. Some patients may experience bradycardia, which is an abnormally slow heart rate, or mild gastrointestinal disturbances like nausea or constipation. In rare instances, patients might notice sleep disturbances, vivid dreams, or a dry mouth. It is essential to monitor your pulse regularly, as a significant drop in heart rate requires medical attention. If you experience shortness of breath, swelling of the ankles, or persistent lightheadedness, consult your healthcare provider immediately. While most side effects are mild and transient as the body adjusts to the medication, any severe reaction or signs of an allergic response, such as skin rashes or difficulty breathing, must be treated as a medical emergency.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Bradycardia | Common | Moderate | Check your pulse regularly. |
| Fatigue | Very common | Mild | Allow your body time to adjust. |
| Dizziness | Common | Moderate | Rise slowly from sitting or lying down. |
How to manage side effects
Bradycardia
- Inform your doctor if your resting pulse is consistently below 50 bpm.
- Do not take the next dose until you have consulted your healthcare provider.
- Your doctor may adjust the dosage.
Fatigue
- Ensure you are getting adequate rest.
- Maintain a consistent sleep schedule.
- If fatigue persists after 4 weeks, discuss a dose review with your physician.
Dizziness
- Avoid sudden movements.
- Stay well-hydrated throughout the day.
- If dizziness leads to fainting, seek medical attention immediately.
How to use Metoprolol Succinate
- Take Metoprolol Succinate 50mg Extended Release Tablet exactly as prescribed by your physician, usually once daily with or immediately after a meal.
- Swallow the tablet whole with a glass of water; do not crush, chew, or break the extended-release tablet.
- Try to take your dose at the same time every day to maintain consistent levels in your bloodstream.
- Do not stop taking this medication abruptly, as this can cause a rebound effect leading to severe chest pain or high blood pressure.
Special population advice
Kidney impairment
- No dosage adjustment needed for mild to moderate impairment.
- Monitor closely in severe renal failure.
Liver impairment
- Use with caution as the drug is metabolized in the liver.
- Consider lower starting doses.
Children
- Not recommended for use in children under 18 years.
- Safety data is insufficient.
Elderly
- Start at the lowest effective dose.
- Monitor for excessive bradycardia and dizziness.
How Metoprolol Succinate works
Metoprolol Succinate acts by selectively blocking beta-1 adrenergic receptors located primarily in the heart. By inhibiting the binding of catecholamines like adrenaline, it decreases the heart rate, reduces myocardial contractility, and lowers blood pressure. This selective action minimizes the risk of bronchospasm compared to non-selective beta-blockers.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Metoprolol Succinate 50mg Extended Release Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a forgotten one, as this may lead to excessive slowing of the heart rate.
In case of overdose
An overdose of Metoprolol Succinate 50mg Extended Release Tablet is a medical emergency. Symptoms include severe bradycardia, hypotension, heart block, and in extreme cases, cardiac arrest or respiratory failure. If you suspect an overdose, seek immediate emergency medical assistance or contact a poison control center. Supportive care, including gastric lavage or activated charcoal, may be initiated by medical professionals.
Treatment is symptomatic and supportive.
- Bradycardia
- Atropine or glucagon may be administered to increase heart rate.
- Hypotension
- Intravenous fluids and vasopressors may be required.
- Bronchospasm
- Beta-2 agonists or aminophylline may be used.
- Cardiac Failure
- Digitalis, diuretics, or inotropic agents may be indicated.
Safety and precautions
When to avoid Metoprolol Succinate
- Sinus bradycardia
Heart rate below 45-50 bpm.
- Second or third-degree heart block
Risk of complete heart block.
- Cardiogenic shock
May worsen cardiac output.
- Decompensated heart failure
May precipitate acute failure.
- Asthma or COPD
Risk of bronchospasm despite selectivity.
- Diabetes
May mask symptoms of hypoglycemia.
- Peripheral vascular disease
May worsen cold extremities.
- Thyrotoxicosis
May mask signs of hyperthyroidism.
Safety at a glance
Alcohol may increase the blood-pressure-lowering effect and dizziness.
Use only if the potential benefit justifies the risk to the fetus.
Monitor the infant for signs of beta-blockade like slow heart rate.
May cause dizziness or fatigue; avoid driving if affected.
No dose adjustment is typically required for renal impairment.
Use with care; dose reduction may be needed in severe hepatic disease.
Do not use if you have a known hypersensitivity to metoprolol.
Safety and efficacy in pediatric patients are not fully established.
Start with a lower dose to avoid excessive bradycardia or hypotension.
Interactions
With other medicines
Verapamil
MajorChanges the medicine’s effect
What can happen: Severe bradycardia and heart block.
What to do: Avoid concurrent use or monitor heart rate and ECG closely.
Fluoxetine
ModerateChanges how the medicine is processed
What can happen: Increased plasma levels of metoprolol.
What to do: Monitor for signs of excessive beta-blockade and consider dose reduction.
Ibuprofen
MinorChanges the medicine’s effect
What can happen: Reduced antihypertensive effect.
What to do: Monitor blood pressure and consider alternative pain relief if necessary.
With food and drink
- AlcoholModerate
Increases risk of hypotension and dizziness.
- High-fat mealsMinor
May slightly increase the bioavailability of the drug.
If you have another condition
- Asthma
Use with extreme caution due to potential bronchoconstriction.
- Diabetes Mellitus
Can mask tachycardia associated with hypoglycemia.
- Psoriasis
Beta-blockers may exacerbate psoriatic symptoms.
Effect on laboratory tests
- Blood Glucose
Altered levels
May interfere with glucose regulation in diabetics.
- Liver Function Tests
Elevated enzymes
Rarely, may cause transient increases in transaminases.
Quick tips
- Monitor your blood pressure and pulse rate at home and keep a log to show your doctor during follow-up visits.
- Avoid sudden changes in posture, such as standing up quickly from a sitting position, to prevent dizziness or fainting.
- Inform your dentist or surgeon that you are taking Metoprolol Succinate 50mg Extended Release Tablet before any procedure, as it may interact with anesthesia.
- Do not consume alcohol while on this medication, as it may intensify the blood-pressure-lowering effects and increase dizziness.
- If you have diabetes, be aware that Metoprolol Succinate 50mg Extended Release Tablet can mask the symptoms of low blood sugar, such as a rapid heartbeat.
Counselling points
- AdherenceImportant
Take the medication at the same time daily.
- Abrupt withdrawalImportant
Do not stop suddenly to avoid rebound hypertension.
- DizzinessGood to know
Rise slowly from sitting or lying positions.
- MonitoringGood to know
Keep a record of your pulse and blood pressure.
Monitoring during treatment
Before starting
- Blood pressure
- Heart rate
- ECG
- Renal function tests
During treatment
- every 3 months: Blood pressure and heart rate monitoring
- annually: Liver and renal function assessment
What is being watched
- Systolic/Diastolic BP
- Pulse rate
- Signs of heart failure
- Blood glucose
Pharmacokinetics
- Absorption
- Rapid and complete, but subject to first-pass metabolism.
- Bioavailability
- Approximately 40-50%.
- Protein binding
- About 12%.
- Volume of distribution
- 3.2 L/kg.
- Half-life
- 3 to 7 hours.
- Metabolism
- Extensively metabolized in the liver by CYP2D6.
- Excretion
- Primarily via urine as metabolites.
- Onset / duration
- Onset within 1 hour; duration 24 hours.
Fact box
- Chemical class
- Selective Beta-1 receptor antagonist
- Habit forming
- No
- Therapeutic class
- Antihypertensive, Antianginal, Antiarrhythmic
- Action class
- Cardioselective beta-adrenoceptor blocker
- Storage
- Store Metoprolol Succinate 50mg Extended Release Tablet at room temperature, away from moisture and direct sunlight. Keep the container tightly closed and out of reach of children and pets.
- ATC code
- C07AB02
- Pregnancy category
- C
More information
Why Clinicians Choose Metoprolol
Metoprolol is frequently the first-line choice for patients with hypertension and comorbid heart conditions because of its proven ability to improve survival rates in heart failure and post-myocardial infarction patients. Its cardioselectivity makes it a safer option for patients with mild respiratory issues compared to non-selective beta-blockers like propranolol. The succinate salt, specifically in the extended-release formulation, provides a smooth, 24-hour therapeutic effect, which is superior for maintaining blood pressure control and preventing the morning surge in blood pressure that often leads to cardiac events. Clinicians value its predictable pharmacokinetic profile and the extensive clinical evidence supporting its long-term safety and efficacy in reducing cardiovascular mortality.
Comparison with Alternatives
When compared to other beta-blockers, metoprolol succinate stands out due to its once-daily dosing convenience. While atenolol is another common beta-1 selective blocker, metoprolol has shown more robust evidence in heart failure management. Unlike carvedilol, which also blocks alpha-receptors and is often used for heart failure, metoprolol is more cardioselective, which can be advantageous in patients who might be sensitive to the vasodilatory effects of alpha-blockade. For patients who cannot tolerate beta-blockers due to severe asthma, clinicians might switch to calcium channel blockers or ACE inhibitors, but for the majority of hypertensive patients with ischemic heart disease, metoprolol remains the gold standard for its balance of efficacy and tolerability.
Lifestyle and Diet Considerations
Patients taking Metoprolol Succinate 50mg Extended Release Tablet should adopt a heart-healthy lifestyle to maximize the benefits of the medication. A low-sodium diet is essential to prevent fluid retention, which can counteract the blood-pressure-lowering effects of the drug. Regular, moderate aerobic exercise is encouraged, but patients should be aware that their heart rate will not rise as high as usual during exertion, so they should pace themselves. Alcohol consumption should be limited, as it can cause sudden drops in blood pressure. It is also important to maintain a healthy weight and avoid smoking, which can interfere with the metabolism of many cardiovascular drugs and worsen the underlying condition being treated.
Common Misconceptions
A common misconception is that beta-blockers like Metoprolol Succinate 50mg Extended Release Tablet are only for people who have already had a heart attack. In reality, they are highly effective for primary prevention in patients with high blood pressure and other risk factors. Another myth is that beta-blockers cause permanent impotence or severe depression in all patients; while these can be side effects, they are not universal, and many patients tolerate the medication without any such issues. Patients often fear that the drug will make them feel 'slow' or 'lethargic'. While some fatigue is common in the first few weeks, this usually subsides as the body adapts to the lower heart rate. It is important for patients to discuss these concerns with their doctor rather than stopping the medication on their own.
References
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
- National Agency for Food and Drug Administration and Control. Metoprolol Tablet ER 50 mg Summary of Product Characteristics.View sourceAccessed
- Drugs.com. Metoprolol Succinate ER Tablets Professional Information.View sourceAccessed
- U.S. Food and Drug Administration. Metoprolol Succinate Extended-Release Tablets Label.View sourceAccessed
- Medical Products Agency. Metoprolol Teva Prolonged-release Tablet Summary of Product Characteristics.View sourceAccessed
Frequently asked questions about Metoprolol Succinate
Can I stop taking Metoprolol Succinate 50mg Extended Release Tablet if I feel better?
No, you must continue taking it as prescribed. Stopping abruptly can cause a dangerous spike in blood pressure or chest pain.
Does Metoprolol Succinate 50mg Extended Release Tablet cause weight gain?
Weight gain is a possible but uncommon side effect; discuss any significant changes with your doctor.
Is it safe to take Metoprolol Succinate 50mg Extended Release Tablet with food?
Yes, taking it with food is recommended to improve absorption and reduce stomach upset.
Will Metoprolol Succinate 50mg Extended Release Tablet affect my exercise performance?
It may reduce your maximum heart rate, which can make intense exercise feel more challenging.
How long does it take for Metoprolol Succinate 50mg Extended Release Tablet to work?
While you may notice some effects within a few days, it can take several weeks to achieve the full therapeutic benefit.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →